This session focuses on the trend of biotechnology sector startups aiming at acquisition as a primary exit strategy and will touch on the subtle strategies required to achieve that goal. This will include insights from seasoned biotech and business professionals. These speakers will discuss the importance of timing, company valuation, and effective negotiation in preparing for an acquisition. The session will also include case studies of recent acquisitions, providing practical examples for a deeper understanding. While targeted at founders and executives of consumer-focused companies in biotechnology, this session offers essential knowledge valuable to companies at all stages of development.